
Please try another search
Phase Holographic Imaging PHI AB (publ), a medical technology company, develops and markets non-invasive time-lapse imaging instruments in Sweden and internationally. The company’s products include HoloMonitor M4, a live cell imaging system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; HoloMonitor app Suite for cell imaging software facilitates kinetic live-cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor for single cell tracking, kinetic dose response and cell motility, cell morphology, wound healing, cell quality control, cell counter, and kinetic cell proliferation assay. It also offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics and interior of HoloMonitor free from condensation. The company’s products are used in cancer research, stem cells, drug discovery and development, single-cell analysis and tracking, cell counting, cell quality check, cell proliferation, cell morphology, cell migration, cell motility and migration, wound healing, and dose responses. Phase Holographic Imaging PHI AB (publ) was incorporated in 1997 and is headquartered in Lund, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Peter Egelberg | 60 | 2004 | Founder, Head of Sales & Marketing and Director |
Goran Dubravcic | 45 | 2023 | Chairman of the Board |
John Alexander Moore | 59 | 2024 | Board Member |
Mats Lundwall | 77 | 2014 | Vice Chairman |
Petter Bjorquist | 60 | 2020 | Director |
Ivan Jurkovic | 41 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review